- Home
- ALDX vs SPE Comparison
ALDX vs SPE Comparison
Compare ALDX & SPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- SPE
- Stock Information
- Founded
- ALDX 2004
- SPE 1993
- Country
- ALDX United States
- SPE United States
- Employees
- ALDX N/A
- SPE N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- SPE Finance/Investors Services
- Sector
- ALDX Health Care
- SPE Finance
- Exchange
- ALDX Nasdaq
- SPE Nasdaq
- Market Cap
- ALDX 160.8M
- SPE 161.1M
- IPO Year
- ALDX 2014
- SPE N/A
- Fundamental
- Price
- ALDX $3.05
- SPE $14.95
- Analyst Decision
- ALDX Strong Buy
- SPE
- Analyst Count
- ALDX 2
- SPE 0
- Target Price
- ALDX $9.50
- SPE N/A
- AVG Volume (30 Days)
- ALDX 769.8K
- SPE 25.4K
- Earning Date
- ALDX 07-31-2025
- SPE 01-01-0001
- Dividend Yield
- ALDX N/A
- SPE 8.55%
- EPS Growth
- ALDX N/A
- SPE N/A
- EPS
- ALDX N/A
- SPE N/A
- Revenue
- ALDX N/A
- SPE N/A
- Revenue This Year
- ALDX N/A
- SPE N/A
- Revenue Next Year
- ALDX N/A
- SPE N/A
- P/E Ratio
- ALDX N/A
- SPE N/A
- Revenue Growth
- ALDX N/A
- SPE N/A
- 52 Week Low
- ALDX $1.14
- SPE $10.26
- 52 Week High
- ALDX $7.20
- SPE $12.59
- Technical
- Relative Strength Index (RSI)
- ALDX 61.89
- SPE 50.38
- Support Level
- ALDX $2.60
- SPE $15.00
- Resistance Level
- ALDX $3.24
- SPE $15.29
- Average True Range (ATR)
- ALDX 0.22
- SPE 0.12
- MACD
- ALDX 0.09
- SPE -0.03
- Stochastic Oscillator
- ALDX 80.93
- SPE 25.94
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About SPE Special Opportunities Fund Inc
Special Opportunities Fund Inc is a closed-ended diversified management investment company. Its investment objective is to have the total return. The company's investment portfolio consists of investment companies, common stocks, money market funds, commodity partnerships, preferred stocks, convertible bonds, liquidating trusts, promissory notes, senior unsecured notes, warrants, rights, corporate notes and corporate bonds. In addition, it also makes investments in construction materials, consumer finance, healthcare equipment and supplies, independent power and renewable electricity producers, insurance, personal products, professional services and real estate investment trusts.